Clinico-pathologic relevance of Survivin splice variant expression in cancer - Test2 - elhamkhani - TriplyDB

Clinico-pathologic relevance of Survivin splice variant expression in cancer

Clinico-pathologic relevance of Survivin splice variant expression in cancer

http://www.wikidata.org/entity/Q38116267

about

Survivin: a unique target for tumor therapy Localization and upregulation of survivin in cancer health disparities: a clinical perspective Nuclear survivin expression: a prognostic factor for the response to taxane-platinum chemotherapy in patients with advanced non-small cell lung cancer.Aberrant splicing and drug resistance in AML Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells.Oral epithelial stem cells - implications in normal development and cancer metastasis.AML sensitivity to YM155 is modulated through AKT and Mcl-1.Suppressed diversity of survivin splicing in active rheumatoid arthritis.Effects of LG268 on Cell Proliferation and Apoptosis of NB4 Cells Survivin splice variants and their diagnostic significance.Protein Sam68 regulates the alternative splicing of survivin DEx3.Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo.Silencing survivin activates autophagy as an alternative survival pathway in HCC cells.High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.Targeting survivin as a potential new treatment for chondrosarcoma of bone.Exosomal survivin facilitates vesicle internalization

P2860

Q26747332-AA5250D0-53C0-438B-A8F4-51CA5EC96092 Q26799719-4CB0B080-1753-43C7-B09E-9ECC66111DD2 Q27853025-721F9466-51F0-4E2F-886D-2B6947B3AF0F Q28076011-5D8BF6D1-41A7-43E5-89B5-2B865EAC9DB5 Q33728161-75A55F09-75A9-463D-8B20-F78FBFAC65F8 Q34147649-45ABDE29-5976-4A32-96A8-4482DB52CD4B Q35983805-FB539E39-EB85-4A79-A8F7-9B061FB158F9 Q36433351-05E1A196-3D76-4F3A-8B63-69FCFA50691C Q37096911-B3BACF95-DEE5-4100-9195-4B8FD93EAADD Q38561421-525B7E6C-5F97-47C1-9861-FBA8ECDD27FD Q38698809-4AADDCDE-E2DA-4562-9F40-CBB22D7E5932 Q38738898-805E09F1-D2EF-402F-8BD9-21B9BAE69802 Q38826310-C4BD2C71-C25D-45BB-8098-8121078751BD Q38976844-61B23DFA-DA72-485B-8C36-8F0ACB6C3C20 Q41026125-B398FD3A-36B1-47E8-9C0A-6625EEE8CD99 Q42419178-ADC54608-EBB6-48C1-9288-C2807C705AE1 Q58579081-75DB2175-5282-46FC-9593-18D7BADABEE8

P2860

Clinico-pathologic relevance of Survivin splice variant expression in cancer

http://www.wikidata.org/entity/Q38116267

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinico-pathologic relevance of Survivin splice variant expression in cancer

@en

type

label

Clinico-pathologic relevance of Survivin splice variant expression in cancer

@en

prefLabel

Clinico-pathologic relevance of Survivin splice variant expression in cancer

@en

P1433

Q38116267-982C367D-052E-4CBE-8BE1-CE86F6E7924B

P1476

Q38116267-E39E3A36-6193-4178-9A96-5E7274B289B5

P2093

Q38116267-1F340024-26D5-47EE-9360-8A1DF11A2BA4

Q38116267-71A25C1E-FA5D-48D7-A264-FBC21AE6035B

Q38116267-820707C6-273B-42C6-BECB-2543EF5E6748

Q38116267-92884714-EB2E-4810-B66A-467E0843DE69

P2860

Q38116267-0D7B3DFA-17FC-4F44-B886-C0B520C4C91D

Q38116267-0FDCAF70-A91E-4721-B99D-D0D14074DAD4

Q38116267-106C10BC-E770-4031-AEBE-65F9126446F5

Q38116267-1AFC02FA-8D16-497E-BD0C-BF648DCDE8F1

Q38116267-1DC7724B-0C71-4D1A-8FD6-96E5D9AB3879

Q38116267-25C64CBD-A395-42D4-9D0E-E7146D168DDE

Q38116267-2CC86BE4-753A-43CA-8DC8-67B88AFF10A3

Q38116267-2F8886E3-D047-4085-B99B-B13D9B31E0C1

Q38116267-358A9448-58EF-40B7-A754-849C32EC3D72

Q38116267-37597C3A-B215-41EA-89D5-4997CD2EA104

P304

Q38116267-54F5406A-8FC5-47AF-B829-0776472A55DF

P31

Q38116267-3BF7B2ED-E9D3-418C-ACC7-12F021953A8A

P356

Q38116267-1F292E62-F242-4916-BAC5-DBF62E7983FC

P407

Q38116267-EEE7824C-2823-4E2C-BAED-6F79EA268E20

P433

Q38116267-7F428010-0456-4A15-97A7-B4362C1BE80F

P478

Q38116267-19F2A4E0-9155-4EB0-B88E-EA037671D650

P50

Q38116267-7BCDE0D1-D492-44EA-9049-048C5669FE99

P577

Q38116267-E39BDD7C-7B5E-485A-B527-00DF621F55B3

P5875

Q38116267-2B318CD6-CFA2-4B0B-B38E-FBC4CF73C42F

P698

Q38116267-63CFFB5C-AECB-48EB-ADE2-DFF13734B588

P932

Q38116267-0492D202-CFA0-4EBE-99E2-427AD60BE5F5

P356

J.CANLET.2013.06.007

P1433

P1476

Clinico-pathologic relevance of Survivin splice variant expression in cancer

@en

P2093

Chien-Shing Chen

http://www.w3.org/2001/XMLSchema#string

Frank D Howard

http://www.w3.org/2001/XMLSchema#string

Rosalia de Necochea-Campion

http://www.w3.org/2001/XMLSchema#string

Saied Mirshahidi

http://www.w3.org/2001/XMLSchema#string

P2860

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties

Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis

Survivin: a protein with dual roles in mitosis and apoptosis

Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity

Survivin monomer plays an essential role in apoptosis regulation

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function

Solution structure of human survivin and its binding interface with Smac/Diablo

Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro

P304

167-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANLET.2013.06.007

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

339

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

241692187

http://www.w3.org/2001/XMLSchema#string

P698

23791888

http://www.w3.org/2001/XMLSchema#string

P932

3775917

http://www.w3.org/2001/XMLSchema#string